Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
PARP Inhibitors
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
Lynparza
(olaparib) / Merck (MSD), AstraZeneca
Zejula
(niraparib) / GSK, J&J
veliparib
(ABT-888) / AbbVie
